首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients
【24h】

Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients

机译:糖尿病血液透析患者的甲状腺功能,心血管事件和死亡率

获取原文
获取原文并翻译 | 示例
           

摘要

Background In dialysis patients, the prevalence of thyroid disorders and their impact on specific cardiovascular (CV) events and mortality are largely unknown. The aim of the present study was to analyze whether subclinical thyroid disorders were associated with CV events and mortality. Study Design Prospective multicenter cohort study. Setting & Participants Thyroid status and clinical outcomes were explored in 1,000 diabetic hemodialysis patients from 178 centers in Germany. Predictor Thyroid status, defined by the following cutoff values: euthyroidism (thyrotropin [TSH], 0.30-4.0 mIU/L; free triiodothyronine [T3], 2.7-7.6 pmol/L; and free thyroxine [T 4], 11.0-24.0 pmol/L), subclinical hyperthyroidism (TSH 0.3 mIU/L and free T3/free T4 within reference ranges), subclinical hypothyroidism (TSH, 4.1-15.0 mIU/L and free T3/free T4 within reference ranges), euthyroid sick syndrome (free T 3 2.7 pmol/L and TSH/free T4 low or within reference ranges). Outcomes During 4 years' follow-up, prespecified adjudicated end points were determined: sudden cardiac death, myocardial infarction, stroke, combined CV events, and overall mortality. Short-term effects within the first 12 months were contrasted to long-term effects (years 2-4). Measurements TSH, free T 3, and free T4 levels at baseline. Results Euthyroidism was present in 78.1% of patients; subclinical hyperthyroidism, in 13.7%; and subclinical hypothyroidism, in 1.6%. Euthyroid sick syndrome was exhibited by 5.4% of patients. The adjusted short-term risk of sudden cardiac death was more than doubled (HR, 2.03; 95% CI, 0.94-4.36) in patients with subclinical hyperthyroidism, and similarly for patients with euthyroid sick syndrome (HR, 2.74; 95% CI, 0.94-7.98) compared with patients with euthyroidism. Short-term mortality was increased almost 3-fold for patients with euthyroid sick syndrome (HR, 2.97; 95% CI, 1.66-5.29), but this effect was not seen in the long term. Subclinical hypothyroidism was not associated with CV events or all-cause mortality. Risks of stroke and myocardial infarction were not affected meaningfully by thyroid disorders. Limitations Observational study design. Conclusions Sudden cardiac death may be influenced by subclinical hyperthyroidism and euthyroid sick syndrome in the short term. Furthermore, euthyroid sick syndrome is associated strongly with mortality in hemodialysis patients. Regular assessment of thyroid status may help estimate the cardiac risk of dialysis patients.
机译:背景技术在透析患者中​​,甲状腺疾病的流行及其对特定心血管(CV)事件和死亡率的影响尚不清楚。本研究的目的是分析亚临床甲状腺疾病是否与心血管事件和死亡率相关。研究设计前瞻性多中心队列研究。背景与参与者从德国178个中心的1,000例糖尿病血液透析患者中​​研究了甲状腺的状况和临床结局。预测甲状腺状态,由以下临界值定义:甲状腺功能亢进(促甲状腺激素[TSH],0.30-4.0 mIU / L;游离三碘甲状腺素[T3],2.7-7.6 pmol / L;和游离甲状腺素[T 4],11.0-24.0 pmol / L),亚临床甲状腺功能亢进症(TSH <0.3 mIU / L和游离T3 /游离T4在参考范围内),亚临床甲状腺功能减退症(TSH,4.1-15.0 mIU / L和游离T3 /游离T4在参考范围内),甲状腺功能亢进综合症(游离T 3 <2.7 pmol / L,TSH /游离T4低或在参考范围内)。结果在4年的随访中,确定了预定的终点:心脏猝死,心肌梗塞,中风,合并CV事件和总死亡率。前12个月内的短期影响与长期影响(2-4年)形成对比。在基线测量TSH,游离T 3和游离T4水平。结果78.1%的患者存在甲状腺功能亢进。亚临床甲状腺功能亢进症,占13.7%;亚临床甲状腺功能减退症占1.6%。 5.4%的患者表现出甲状腺疾病综合症。在亚临床甲状腺功能亢进患者中,调整后的突发性心脏猝死的短期风险增加了一倍以上(HR,2.03; 95%CI,0.94-4.36),甲状腺功能亢进综合症患者(HR,2.74; 95%CI, 0.94-7.98)与甲状腺功能正常的患者相比。甲状腺疾病综合症患者的短期死亡率几乎增加了三倍(HR,2.97; 95%CI,1.66-5.29),但长期来看没有这种效果。亚临床甲状腺功能减退症与心血管事件或全因死亡率无关。中风和心肌梗塞的风险并未受到甲状腺疾病的显着影响。局限性观察性研究设计。结论亚临床甲状腺功能亢进症和甲状腺功能亢进综合症在短期内可能会导致心源性猝死。此外,甲状腺功能正常病综合症与血液透析患者的死亡率密切相关。定期评估甲状腺状况可能有助于估计透析患者的心脏风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号